Asia Vital Components (3017) Q1 2025 earnings summary

Executive summary

• Q1'25 sales revenue reached NTD 23,333 million, up 52.41% year-over-year and 11.62% sequentially from Q4'24.

• Net income attributable to parent company was NTD 3,214 million, a 105.50% increase year-over-year and 37.47% higher than Q4'24.

• EPS for Q1'25 was NTD 8.28, up 102.94% year-over-year and 37.31% sequentially.

• Gross margin improved to 25.83%–26% in Q1'25 from 22.03%–22% in Q1'24.

• Diluted EPS for Q1'25 was NTD 8.06, up from NTD 3.95 in Q1'24.

Financial highlights

• Operating income rose 125.37% year-over-year to NTD 4,361 million, with operating margin at 18.69%–19%.

• Free cash flow increased 35.60% year-over-year to NTD 4,346 million.

• Cash and cash equivalents at period end were NTD 34,492 million, up 19.61% year-over-year.

• Total assets as of March 31, 2025 were NTD 111,825 million, up from NTD 74,786 million a year earlier.

• Shareholders’ equity increased to NTD 33,353 million from NTD 25,227 million year-over-year.

Outlook and guidance

• Revenue and EPS have shown strong CAGR over recent years: revenue CAGR 16.26%, EPS CAGR 48.10% from 2018 to 2024.

• Management continues to monitor market and industry conditions, focusing on growth and profitability.